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1. Introduction 
Neoplasms of diverse cellular origin arise in the oral cavity and among these oral squamous 
cell carcinoma (OSCC) arising from the mucosa of the oral cavity constitutes to over 90%1, 2. 
Oral cancer encompasses all the malignancies originating in the oral tissues, including 
cancers of the lip, tongue, gingiva, floor of the mouth, buccal mucosa, palate and the 
retromolar trigone. It is the 6th most common cancer worldwide3. Oral squamous cell 
carcinoma is described as an invasive epithelial neoplasm with varying degrees of 
squamous differentiation and a propensity to early and extensive lymph node metastases, 
occurring predominantly in alcohol and tobacco using adults generally in the 5th and 6th 
decades of life.  
Globally about 5, 00,000 new cases of oral and oropharyngeal cancers are diagnosed and 
three quarters of these are from the developing world7, 8, 9. Approximately 3, 89,650 cases 
occurred in the year 2000 out of which 2, 66,672 were in the oral cavity (ICD – 9 140 – 5) and 
1, 22,978 for the cancer of oropharynx (ICD – 9 146, 8-9). This represented about 5% of all 
cancers for men and 2% for women10. Oral and oropharyngeal cancers remain one of the 
more common cancers in the South and South East Asian countries, as opposed to Western 
society, where it accounts for only about 1 – 4% of the of reported cancers incidence 4. For 
example, the incidence of oral cancer in India is high, constituting about 12% of all cancer in 
men and 8% in women5; mortality rate is equally high in this population, ranking number 
one in men and number three in women6. Oral and oropharyngeal cancers therefore qualify 
as major public health problem, not only in India, but also globally. 
Worldwide, oral cancer incidence rates appear to have been stabilizing over the last 
decade12, but the greater frequency of oral cancer in certain regions and among specific 
populations is a cause for concern since their overall 5-year survival rate is 53% and it has 
not changed in the last two decades13. With this heightened awareness, research to further 
investigate the detection, diagnosis and prevention or oral cancer has recently been included 
as one of the targeted priorities supported by the National Institute of Dental and 
Craniofacial Research (NIDR) in the United States14.  
The overall 5 - year survival rate for patients without clinically evident cervical lymph node 
metastases is 85% . However, patients with microscopic lymph node metastases have a 
survival rate of 54%. It has been estimated that 20-50% of patients without clinically evident 
cervical lymph node metastases do in fact have microscopic metastases and therefore poorer 
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prognosis87. Among the Indian population, the overall 5- year observed and relative 
survival rates were 30.5% and 39.7%, respectively. Survival steadily declined with 
advancing age and advanced clinical stages. 5-year observed survival was 59.1% for 
localized cancer, 15.7% for cancers with regional extension and 1.6% for those with distant 
metastasis. Those with tongue, buccal mucosa and retromolar trigone cancers had poor 
survival rates11. 
2. Risk factors for oral cancer  
The cancer epidemic in developed countries, and increasingly in developing countries, is 
due to the combined effect of the ageing of populations, and the high or increasing levels of 
prevalence of cancer risk factors15. About 95% of patients with oral cancer are over 40 years 
of age at diagnosis, and the mean age at diagnosis is 60 years. The association of oral cancer 
with increasing age is consistent with the disease process being related to environmental 
risk factors. Risk rises dramatically among males from about 7/1, 00,000 at the age of 30 to 
approximately 80/1, 00,000 for the 60 year old15.  
The development of oral cancer in many cases appears to be due to chronic exposure to 
topical carcinogens, notably tobacco and alcohol16 proposed to interact synergistically to 
increase cancer. However, there is a distinct geographical variation among the risk factors 
contributing to oral cancer. In the Western population exposure to sunlight (lip cancer), 
cigarette-smoking, and alcohol consumption are the frontline etiologic culprits compared 
with the use of smokeless tobacco and combustible tobacco more prevalent in the South East 
Asian countries17.  
The concurrent use of tobacco and alcohol accounts for 75% of all oral cancers18. Other risk 
factors for oral cancers includes over exposure to sun rays, particularly the cancer of the lip, 
and malnutrition or poor dietary intake of essential minerals19. Currently the role of viruses 
such as human papillomavirus20, 21, 22, 23 is also implicated as a major risk factor. They are 
believed to induce cancers by altering the DNA and the chromosomal structures of the cells 
and by inducing proliferative changes of the cells they infect.  
An increased consumption of fruits and vegetables is associated with lower risk of oral 
cancers24. Thus, primary preventive measures in oral cancer includes, avoidance of tobacco 
and alcoholic intake, avoiding exposure to certain viruses and exposure to sunlight and 
consumption of fruits and vegetables.  
Tobacco: Overwhelming majority of carcinomas is closely linked to tobacco usage in various 
forms. Tobacco may be consumed as smoking tobacco or smokeless tobacco. It is used in 
various forms such as chewing tobacco, oral use of snuff, smoking of cigars, cigarettes, bidis, 
pipes, among others (Table – 1.1).  
The smoking of tobacco is a widespread habit practiced by people from most cultures and 
societies throughout the world. While the custom of tobacco smoking is almost universal in its 
occurrence, there is considerable variation with respect to the amount of tobacco smoked and 
the form in which it is smoked. Smokeless tobacco is tobacco that is not burnt when it is used 
and is usually placed in the oral or nasal cavities against the mucosal sites that permit the 
absorption of nicotine into the human body. The two main types are the chewing tobacco and 
snuff. It may be used alone or in combination with other substances such as lime. 
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Smoking Tobacco 
Cigarette 
Finely cured tobacco treated with sugars, flavoring agents wrapped 
in paper. 
Bidi 
Small quantity of shredded sun cured tobacco which is hand rolled 
into a piece of tendu (temburni tree leaf – Diospyrous melanoxylon). 
Cigars 
Made of cigar tobaccos, wrapped in a tobacco leaf, paper or 
reconstituted tobacco. 
Chutta 
Hand made cigar containing cured tobacco in a dried tobacco leaf 
wrapping.  
Pipe – 
Briar Pipe, 
Meerschaum Pipe 
(England), 
Chillum (India) 
Pipe tobaccos are of variable composition usually consist of blended 
tobaccos to which sugars and flavoring agents such as liquorices are 
added. 
Smokeless tobacco 
Chewing tobacco 
Plug tobacco, loose leaf tobacco and twist (roll) tobacco (Western 
World).  
Khaini, Pattiwala tobacco, Mainpuri tobacco, Mishri, Zarda, Kiwam, 
Gudakhu, Shammah, Nass, Naswar. 
Snuff 
A moist type, consisting of very finely cut tobacco which is used in 
the mouth and a dry type, which is finely pulverized tobacco and 
which is used orally or nasally. 
Table 1.1. Different forms of tobacco and usage 
Among the different smoking habits, the cigarette or cigar increased the risk of cancer by 6 
times, hookah and pipe by 16 times and bidi smoking by 36 times25 as compared to non 
smokers. In the largest population-based case-control study of oral cancer yet conducted16, 
strong positive trends in risk were observed according to amount and duration of each type 
of tobacco and amount of alcohol consumption. Relative to nonsmokers, heavy cigarette 
smokers (40+/day for 20+ years) experienced a four-fold risk (men) and ten-fold risk 
(women) after adjusting for alcohol intake. After controlling for smoking, moderate drinkers 
(15-29 alcoholic drinks/week) had a three-fold risk of oral cancer and heavy drinkers (> 30 
drinks/week) experienced an eight- to nine-fold risk. Combined heavy smoking and 
drinking resulted in a greater than 35-fold excess risk.  
The chewing of quid containing betel leaves, tobacco, and lime and the smoking of bidi 
contribute to the majority of cases in parts of India and Southeast Asia26, 27. Among users of 
snuff, cancerous lesions typically arise at the site where smokeless tobacco or quid, is held in 
contact with the buccal mucosa or gingiva. Although not as prevalent as cigarette smoking, 
habitual use of pipes, cigars, and smokeless tobacco is associated with relative risks for 
cancers of the mouth as great as that for cigarette smoking28. The site of origin of oral cancer 
usually corresponds to the placement of tobacco quid29. The patients who chewed and 
smoked tobacco together had a tenfold higher risk of cancer of the oral cavity relative to the 
non-chewing, non-smokers, whereas the patients who only chewed tobacco had a six fold 
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higher risk of cancer and the patients who only smoked had a threefold increase in the same 
risk30. It has also been demonstrated that the relative risk of chewing betel quid without 
tobacco for oral cancer was lowered compared to chewing betel quid with tobacco31. The 
role of areca nut in oral carcinogenesis is a matter of debate, however, areca nut and lime 
when used has had a definite carcinogenic effect, even when chewed without tobacco32.  
Tobacco consumption is positively correlated with accumulation of DNA damage, and 
exposure to tobacco related chemical carcinogens could provide direct damaging effects on 
the cellular DNA in the human oral cavity33, 34. DNA damaging agents found in tobacco 
include benzi (a) pyrene (B (a) P) and tobacco specific N’-nitrosamines (TSNAs). Examples 
of TSNAs are N nitrosonornicotine (NNN) and 4- [methylnitrosoamino]-1-[3-pyridyl]-1-
butanone (NNK) and these chemicals exhibit carcinogenicity in animals33, 35. In fact, 
damaged genomic DNA has been detected as DNA adducts in various tissues of cigarette 
smokers36, 37. Nitrosamines contain the organic functional group N-N=O, and are formed by 
the nitrosation (addition of an N=O group) of secondary and tertiary amines. Another 
chemical term for these tobacco amines is an “alkaloid”, an organic base that contains 
nitrogen and is located in a seed plant. TSNA are created during fermentation, curing and 
burning of the tobacco leaf. These findings strongly suggest a causal role of tobacco use in 
oral carcinogenesis38.  
Alcohol: The independent risk of alcohol in oral cancer etiopathogenesis is uncertain as 
most of the alcohol users are smokers as well. Alcohol is thought to be associated with 
carcinogens through several mechanisms in that it may damage the oral mucosa through a 
direct effect on cell membranes, removing lipids and increasing the permeability of the oral 
mucosa to noxious carcinogenic substances. It also has systemic effects and alcohol related 
liver damage may potentiate the action of carcinogens in the oral mucosa by reducing the 
body’s ability to detoxify harmful compounds. Alcohol also has immunosuppressive effect 
and this together with a degree of nutritional deficiency may also contribute to the 
carcinogenic process. In addition, acetaldehyde a direct metabolite of alcohol is a carcinogen 
and may be produced both systemically and by the oral micro flora. 
Viruses: Both RNA-containing and DNA-containing viruses have been identified as 
carcinogenic. These viruses may incorporate one or more of the functional genes into the 
host DNA and secondly the persistent expression of this viral genome may maintain the 
host cell in the transformed state. Although Epstein – Barr virus (EBV), Herpes Simplex 
viruses (HSV), Retroviruses and Human papillomaviruses (HPVs) have all been implicated 
to play a role in the development of oral carcinoma, HPV is increasingly highlighted as a 
risk factor in oral carcinogenesis39, 40, 41, 42. 
HPVs, especially those genotypes of known high oncogenic potential in uterine cervix and 
skin such as HPV 16 and 18, are found in a variable but small proportion of oral cancers. 
This has lead to the speculation that HPV infection, perhaps arising from oral/ genital 
contact, might be important in some cases. Of interest is the observation that HPV 
containing cancers at these sites do not generally show TP53 mutations, contrary to HPV 
DNA negative cancers43. 
It is well known that E6 protein from “high risk” HPV interact with E6 associated protein 
(E6/E6-AP) complex, which binds to and induces degradation of p53 protein44, 45. ”High 
risk” HPV infection, however, directly abrogates the innate check point mechanisms against 
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such environmental challenge, resulting in the accumulation and propagations of mutations. 
Hence, the viral infection in combination with existing chemical carcinogens may be the 
paramount causative agents for the development of oral cancer46.  
Diet and deficiency states: Recent epidemiologic studies have indicated that diet may play 
an important role in the origin of these cancers. Findings have pointed to the protective 
effects of a diet consistently high in fresh fruits; vegetables; vitamins A, C, and E; and 
carotenoids, even with adjustment for alcohol intake and smoking47, 48, 49, 50, 51. A reduced 
risk of oral cancer associated with vitamin E supplementation has been shown in one 
study52. Certain deficiency states may cause epithelial atrophy, which renders the 
epithelium vulnerable to action of carcinogens. Vegetarianism versus non vegetarianism has 
failed to show any role in oral cancer development53. High levels of carotenoids have been 
shown to be strongly related to lower risk of oral cancer development. The possible role of 
micronutrient ingestion with an associated antioxidant effect has been emphasized. Natural 
carotenoid compounds, dietary selenium, folate and vitamin A, C and E have been stated to 
offer protective effects regarding cancer development54. Iron deficiency anemia, a relatively 
common disorder, may produce atrophic oral changes (as seen in patients with Plummer-
Vinson syndrome) that may predispose to malignant transformation55.  
Oral cancer affects men more often than women because of heavier indulgence in both 
tobacco and alcohol habits in most countries58, 59. However, in India the oral cancers are also 
common among women due to tobacco chewing habits. The male to female ratios, globally, 
however, is lower for cancer of the oral cavity than for cancer of the oropharynx, perhaps 
suggesting that higher exposure to tobacco smoking and alcohol drinking are required to 
induce oropharyngeal than oral cancer60. An epidemiological review on oral cancer in India 
showed that the mean age was 57.1 years for males and 58.6 years for female patients with 
peak age frequency in the sixth decade for men and seventh decade for women5. 
Other factors: Carcinoma of the vermilion border of the lip is more often linked to working 
outdoors in fair skinned individuals regularly exposed to sun light. This has been 
attributable to the effect of UV radiation26, 56. Orodental factors like poor oral hygiene, faulty 
restorations, sharp teeth and ill-fitting dentures may also play a role in the etiology of oral 
cancers57.  
3. Clinical features  
The clinical features of oral cancer differ considerably for different intraoral locations. 
Patients with small oral and oropharyngeal SCC are often asymptomatic or may present 
with vague symptoms and minimal physical findings. Hence, a high index of clinical 
suspicion is needed to diagnose small lesions, especially if the patients have tobacco and 
alcohol habits. Patients may present with red lesions, mixed red and white lesions or white 
plaques. Co existing white plaques may be observed adjacent to carcinomas and this implies 
an origin in a pre existing white lesion though the prevalence of this association varies 
considerably. However, most patients present with signs and symptoms of locally advanced 
disease. The clinical features may vary according to the affected intra oral site. Mucosal 
growth and ulceration, pain from the lesion, referred pain to the ear, malodor from the 
mouth, difficulty with speaking, discomfort while chewing, pain with swallowing, weight 
loss, swelling in the neck are the common presenting symptoms of locally advanced oral 
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cancers. Occasionally patients present with enlarged neck nodes without any symptoms 
from oral or oropharyngeal lesions. Extremely advanced cancers present as 
ulceroproliferative growths with areas of necrosis and extension into the surrounding 
structures. In the advanced stages patients may present with orocutaneous fistula, 
intractable bleeding, severe anaemia and cachexia.  
Tumors may arise in any part of the oral cavity and its preferential occurrence varies with 
the geographical domain reflecting different risk factors. Within the oral cavity, oral cancer 
may be localized to buccal mucosa, upper and lower gingiva, hard palate, anterior two 
thirds of the tongue, including the dorsal, ventral and lateral surfaces, and floor of the 
mouth. The most common oropharyngeal site of involvement for SCC is the base of tongue.  
Oral cancers have a varied clinical presentation in that they may be exophytic or endophytic. 
Exophytic lesions typically have surfaces that are irregular, fungating, papillary or 
verruciform and its color may vary from normal to red to white, depending on the degree of 
vascularity and the amount of surface keratin. The surface is often ulcerated, and the tumor 
feels indurated on palpation. The endophytic growth pattern is characterized by a 
depressed, irregularly shaped, ulcerated central area with a surrounding “rolled” border of 
normal, red or white mucosa. The rolled border results from invasion of the tumor 
downward and laterally under adjacent epithelium.  
Carcinoma of the lip is typically found in light skinned persons with either long term 
exposure to ultraviolet radiation from sunlight or a history of sunburn early in life. It also 
may arise at the site where a cigarette, cigar or pipe stem is held by the patient. Almost 90% 
of lesions are located on the lower lip. The typical vermilion carcinoma is a crusted, oozing, 
non tender, indurated ulceration that is usually less than 1cm in its greatest diameter. The 
tumor is characterized by a slow growth rate and metastasis is a late event61, 62.  
The most common intraoral carcinoma is the tongue, usually the posterior-lateral and 
ventral surfaces. Cancer of the tongue may appear as a red area interspersed with nodules 
or as an ulcer infiltrating deeply, leading to reduced mobility of the tongue. These tumors 
are painful. Advanced stages are associated with drooling. Lesions near the base of the 
tongue are particularly insidious, since they may be asymptomatic until they attain 
advanced stage. Even then the only manifestation may be a sore throat and dysphagia. The 
specific site of development of these tumors is of great significance, since the lesions on the 
posterior portion of the tongue are usually of a higher grade of malignancy, metastasize 
earlier and offer a poorer prognosis, especially because of their inaccessibility for early 
diagnosis and treatment. Metastasis occurs with greater frequency in cases of tongue cancer. 
In India, the cancers over the anterior 2/3 of tongue are related to the tobacco chewing habit 
and posterior 1/3 lesions are related to bidi smoking63, 64.  
Carcinoma of the floor represents 15 – 30% of all intra oral cancers. Cancers of the floor of 
the mouth may arise as a red area, a small ulcer or as a papillary lesion. Most patients 
present with discomfort or irritation at the site of the tumor. This type of cancer affecting 
predominantly the males of the higher age group has shown to be associated with tobacco 
usage and alcohol drinking65. The typical carcinoma in the floor of the mouth is an 
indurated ulcer of varying size situated on one side of the midline. Because of its location, 
early extension into the lingual mucosa of the mandible and into the mandible proper as 
well as into the tongue occurs with considerable frequency. Of all intra oral carcinomas, oral 
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floor lesions are the most likely to arise from a preexisting leukoplakia or erythroplakia. It is 
also the oral cancer site most often associated with the development of a second primary 
malignancy of another aerodigestive tract location or a distant organ. Metastasis from the 
floor of the mouth are found most commonly in the submandibular group of lymph nodes 
and since the primary lesion frequently occurs near the midline where a lymphatic drainage 
occurs contra lateral metastases are often present66.  
Cancer of the buccal mucosa may present as an ulcer with indurated raised margin, 
exophytic or verrucous on the side with the placement of betel quid. In advanced stages 
these lesions infiltrate into the adjacent bone and overlying skin. Leukoplakia is a common 
predecessor of carcinoma of buccal mucosa and they originate in the commissural areas and 
spreads posteriorly. The most common sites of metastases are the sub maxillary 
lymphnodes67, 68.  
Carcinomas from gingiva and alveolar ridge are usually painless and most frequently arise 
from keratinized mucosa. It is generally agreed that carcinoma of the mandibular gingiva is 
more common that the involvement of maxillary gingiva. Carcinoma of the gingiva usually 
manifested initially as an area of ulceration which may be purely erosive or may exhibit an 
exophytic granular or verrucous type of growth. The tumor arises more commonly in 
edentulous areas, although it may develop in a site in which teeth are present. The attached 
gingiva is more frequently involved than the free gingiva. The proximity of the underlying 
periosteum and bone usually invites early invasion of these structures. In maxilla, gingiva 
carcinomas often invade into the maxillary sinus, or it may extend onto the palate or into the 
tonsillar pillar. In the mandible, extension into the floor of the mouth or laterally into the 
cheek as well as deep into the bone is rather common. Of all the intra oral carcinomas, this 
one is least associated with tobacco smoking and has the greatest predilection for females69.  
Tumors of the alveolar ridge may occasionally present difficulty in wearing dentures or may 
present loose teeth associated with pain and bleeding during brushing of teeth. Tumors of 
the hard palate are not particularly common lesions and palatal carcinomas usually 
manifests itself as a poorly defined, ulcerated, painful lesion on one side of the midline. It 
crosses the midline, and may extend laterally to include the lingual gingiva or may 
posteriorly extend to involve the tonsillar pillar or uvula. Tumors of the hard palate often 
presents as papillary or exophytic growths, rather than a flat or ulcerated lesion.  
Cancers of the soft palate and oropharyngeal mucosa has the same basic clinical appearance 
as more anterior carcinomas, except that in this posterior location the patient often is 
unaware of its presence and the diagnosis may be delayed. The tumor site is greater than 
that of more anterior carcinomas and the proportion of cases with cervical and distant 
metastasis at diagnosis is higher70.  
4. Relevant diagnostic procedures  
Early detection of cancer is the most effective means of reducing mortality. Accurately 
identifiable biomarkers for early detection may provide newer avenues and constitute 
potential targets of cancer and its risk assessment. Screening for oral cancer should include a 
thorough history and physical examination. The clinician should visually inspect and 
palpate the head, neck, oral and pharyngeal regions. This procedure involves digital 
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palpation of neck node regions, bimanual palpation of the floor of mouth and tongue. 
Protraction of the tongue with gauze is necessary to visualize fully the posterior lateral 
tongue and tongue base. The clinician should review the social, familial and medical history 
and should document risk habits, a history of head and neck radiotherapy, familial history 
of head and neck cancer and a personal history of cancer.  
The diagnosis is confirmed by biopsy. The specimen is taken from the clinically most 
suspicious area, avoiding necrotic or grossly ulcerated areas and biopsy specimens from 
more than one biopsy site may need. In patients with enlarged cervical lymph nodes and an 
obvious primary in the oral cavity, the biopsy is always taken from the primary site and not 
from the lymph node. In such situations, fine needle aspiration cytology may be carried out 
to verify the involvement of the node. If no obvious primary site is found in patients 
presenting with neck nodes, fine needle aspiration of the lymph node can be performed to 
help establish the diagnosis. In patients for whom fine needle aspiration is non diagnostic, 
excisional lymph node biopsy is required. Patients with SCC of the oral cavity or 
oropharynx have a risk of multiple primary tumors in the pharynx or larynx, as well as in 
the tracheobronchial region and oesophagus so routine panendoscopy is often performed to 
evaluate these sites.  
Imaging: Intra oral and dental radiographs, in combination with orthopantomography, may 
help in identifying involvement of the underlying bone. Three dimensional imaging with 
computed tomography (CT) and magnetic resonance imaging (MRI) is frequently used to 
supplement the clinical evaluation and staging of the primary tumor and regional lymph 
nodes. CT scan or MRI gives more information about the local extent of the disease and also 
help to identify lymph node metastases. MRI is more informative when evaluating the 
extent of soft tissue and neurovascular bundle involvement. The combination of soft tissue 
characterization and anatomical localization afforded by CT and MRI make them valuable 
tools in the preoperative assessment of patients. Distant metastasis from oral cancer is 
uncommon at presentation. At minimum, a routine radiograph of the chest is performed to 
rule out lung metastases.  
5. Tumor spread 
Local spread of oral SCC, in the early stages, is relatively predictable in tissues that have not 
been previously irradiated. It is influenced by local anatomical features. Lip SCC spreads 
superficially and then into deeper tissues. Floor of mouth SCC spreads superficially rather 
than in depth, invading into the myelohyoid muscle or the sublingual gland only at late 
stage. Tumor involving the lateral margin of tongue, whether arising there directly or by 
superficial spread from the floor of mouth, tends to spread deep within the tissue. The 
intrinsic muscles of tongue run in small bundles in all directions such that invading tumor 
encounters some muscle running at right angles to the surface. Tumors of palate spread 
superficially rather than deep and this is also true for more posterior tumors of the 
oropharynx.  
Spread of SCC into bone is a frequent problem. The mandible is involved much more 
frequently than the maxilla. Tumors in the mandible can involve the inferior alveolar nerve 
with a particular likelihood of spread posteriorly along the nerve. Cancers arising in gingiva 
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or alveolus and those involving these sites by extension from adjacent sites are unlikely to 
invade into the mandible71.  
Tumor spread in previously irradiated soft tissues tends to be more extensive and less 
predictable than in normal tissues and as a consequence requires more extensive surgery if 
excision is attempted. Spread to local lymph nodes worsens the prognosis in oral and 
oropharyngeal cancer. The mechanism of spread from primary site to lymph nodes is almost 
always by dissemination. The lymph nodes in the neck are divided into levels. The 
lymphatic drainage from the head and neck sites is relatively predictable72.  
Levels at high risk for metastasis from OSCC are level I, II and III and to a lesser extent level 
IV. Although Level II is the most frequently involved, some tumors spread to Level III or IV, 
with or without involvement of Level I. This has given rise to the concept of skip metastasis. 
Bilateral spread to the neck is likely to occur from tumors involving the midline, especially 
tumors of the posterior tongue or soft palate. Extra capsular spread of tumor involving 
lymph nodes is associated with a poor prognosis. There have been many studies attempting 
to predict the presence of lymphatic spread from features of the primary tumor66, 73.While 
the implementation of multi-modality neoadjuvant therapy for the treatment of head and 
neck cancer has resulted in an improvement in local regional control, there has been a 
resultant increase in the reported incidence of distant metastasis. This shift in the pattern of 
patient treatment failure highlights the importance of identifying patients at high risk of 
developing metastasis, accurately detecting metastasis, and improving treatment strategies 
for advanced disease. Currently, metastatic lesions from head and neck primaries portend a 
poor prognosis73. 
Pattern of the invasive front is a useful predictor in that a non cohesive front is associated 
with increased likelihood of metastases. Other factors associated with increased risk of 
metastases are perineural spread at the invasive front, lymphovascular invasion and tumor 
thickness. For diagnostic purposes, a thickness of 5mm or greater is used as indicating 
increased risk of nodal spread74. Until recently hematogeneous spread of oral cancer had 
been regarded as less important than local and lymphatic spread. However, its importance 
is increasing as loco-regional control improves. Blood borne spread most often involves 
lung75, 76. The best predictor of the likelihood of spread is involvement of the neck at multiple 
levels. This suggests that the route of entry of tumors into the circulation is most often via 
the large veins in the neck and that haematogenous spread is in effect tertiary spread 
following extracapsular spread from neck nodes.  
6. Staging  
Clinical staging refers to an assessment of the extent of the disease before undertaking 
treatment. The purpose of staging is for the selection of the most appropriate treatment plan, 
for meaningful comparison of the end results reported from different sources and for 
determining tumor size, extent of metastasis, and other indicators of patient prognosis.  
TNM clinical classification if carcinomas of the lip and oral cavity77, 78 
T – Primary tumor 
TX – Primary tumor cannot be assessed 
T0  – No evidence of primary tumor 
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Tis – Carcinoma in situ 
T1  – Tumor 2cm or less in its greatest dimension 
T2  – Tumor more than 2cm but not more than 4cm in greatest dimension 
T3  – Tumor more than 4cm in greatest dimension  
T4a (Lip) 
 – Tumor invades through cortical bone, inferior alveolar nerve, floor of mouth or 
 skin (Chin or nose) 
T4b (Oral cavity) 
 – Tumor invades through cortical bone, into deep / extrinsic muscles of the tongue 
 (genioglossus, hyoglossus, palatoglossus and styloglossus), maxillary sinus or skin 
 of face  
T4b (Lip and oral cavity) 
 – Tumor invades through masticator space, pterygoid plates, or skull base or 
 encases internal carotid artery  
NOTE  – Superficial erosion alone of bone/ tooth socket by gingival primary is not 
 sufficient to classify tumor as T4 
N – Regional Lymph nodes (Cervical nodes) 
NX  – Regional lymph nodes cannot be assessed 
N0  – No regional lymph node metastasis 
N1  – Metastasis in a single ipsilateral lymph node, 3cm or less in greatest dimension. 
N2 – 
N2a – Metastasis in a single ipsilateral lymph node, more than 3cm but not more than  
 6 cm or less in greatest dimension. 
N2b  – Metastasis in multiple ipsilateral lymph nodes, none more than 6 cm in greatest 
 dimension. 
N2c – Metastasis in bilateral or contralateral lymph nodes, none more than 6 cm in 
 greatest dimension 
N3  – Metastasis in a lymph node more than 6 cm in greatest dimension 
Note   – Midline nodes are considered ipsilateral nodes. 
(M)  – Distant metastasis 
MX  – Distant metastasis cannot assessed 
M0  – No evidence of distant metastasis 
M1  – Distant metastasis is present 
7. Stage grouping  
 
Stage 0 Tis  N0 M0 
Stage I T1 N0 M0 
Stage II T2 N0 M0 
Stage III T1,2,3 N1 M0 
Stage IVA 
T1,2,3 N2 M0 
T4a N0,N1,N2 M0 
Stage IVB 
Any T N3 M0 
T4b Any N M0 
Stage IVC Any T Any N M1 
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8. Grading 
Squamous differentiation, often seen as keratinization with variable “pearl” formation and 
invasive growth are the prerequisite features of SCC. Invasion is manifested by the 
disruption of basement membrane and extension into the underlying tissue, often 
accompanied by stromal reaction. Angiolymphatic and perineural invasion are additional 
signs of malignancy.  
The tumors are traditionally graded into well – moderately - , and poorly differentiated 
SCC. Well differentiated SCC resembles closely normal squamous epithelium. Moderately 
differentiated SC contains distinct nuclear pleomorphism and mitotic activity, including 
abnormal mitoses; there is usually less keratinization. In poorly differentiated SCC, 
immature cells predominate, with numerous typical and atypical mitoses and minimal 
keratinization. Most SCC is moderately differentiated, so grading by differentiation is really 
of limited prognostic value, as compared to pattern of invasion. Broder’s82 grading was the 
first of the systems which initiated quantitative grading of cancer. This classification system 
was based on the estimated ratio of differentiated to undifferentiated elements in the tumor. 
The author suggested a grading system in which a grade I lesion was highly differentiated 
(its cells were producing much keratin), while grade IV were poorly differentiated (cells 
were anaplastic and showed no keratin formation) (Tab 1.2). 
 
Grade I: 
 Numerous epithelial pearls, considerable cellular keratinization with 
inter cellular bridges; 
 Less than 2 mitoses per high power field,  
 Atypical mitosis and multinucleated giant cells rarely present, 
minimal nuclear and cellular pleomorphism. 
Grade II: 
 Epithelial pearls infrequent or even absent; neither keratinization of 
individual cells nor the presence of intercellular bridges; 
 2-4 mitoses per high power field with occasional atypical mitosis; 
 Moderate pleomorphism of cells and nuclei. 
Grade III: 
 Epithelial pearls rarely seen; negligible cellular keratinization and no 
inter cellular bridges; 
 More than 4 mitoses per high power field with frequent atypical 
mitoses, cellular and nuclear pleomorphism marked. 
Grade IV:   Highly anaplastic, practically no keratin formation 
Table 1.2. Histologic Grading of Oral Cancer82  
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Later Anneroth et al developed a much better classification system in 198779 (Tab 1.3) 
 
Morphologic 
parameters 
1 2 3 4 
Degree of 
keratinization 
Highly 
keratinized  
(50% of cells) 
Moderately 
keratinized 
(20-50% of cells) 
Minimal 
keratinization 
(5-20% of cells) 
No 
Keratinization 
(0-5% of cells) 
Nuclear 
Polymorphism 
Little nuclear 
polymorphis
m (>75% 
mature cells) 
Moderate to 
abundant 
nuclear 
polymorphism 
(50-70% mature 
cells) 
Abundant 
nuclear 
polymorphism 
(25-50% mature 
cells) 
Extreme 
polymorphism 
(0-25% mature 
cells) 
Number of 
mitosis/high 
power field 
0-1 2-3 4-5 >5 
Pattern of 
invasion  
Pushing, well 
delineated 
infiltrating 
border 
Infiltrating solid 
cords, bands of 
strands 
Small groups of 
cords of 
infiltrating cells  
Marked and 
wide spread 
cellular 
dissociation in 
small groups 
Stage of 
invasion 
Carcinoma in 
situ or 
questionable 
invasion 
Direct invasion 
but involving 
lamina propria 
only 
Invasion below 
lamina propria 
adjacent to 
muscle, 
salivary gland 
and periosteum 
Extension and 
deep invasion 
replacing most 
of the stromal 
tissue and 
infiltrating jaw 
bones 
Lympho-
plasmocytic 
invasion 
Marked Moderate Slight  None  
Table 1.3. Histologic Grading of Malignancy of tumor cell population (points) 
All the above features are graded in the most poorly differentiated parts of the tumors. Each 
morphologic feature is graded from 1 to 4, and a total malignancy score is the sum of scores. 
A high total score indicates a poor prognosis. However this system had a few drawbacks as 
it was complicated and time consuming. Besides which the evaluations of features were 
dependent on a large and representative biopsy.  
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Invasive front 
Tumor growth at the invasive front can show an expansive pattern, an infiltrative pattern or 
both. Expansive growth pattern is characterized by large tumor islands with well defined 
pushing margins and is associated with a better prognosis. Infiltrative growth pattern is 
characterized by scattered small irregular cords or single tumor cells, with poorly defined 
infiltrating margins and is associated with a more aggressive course80. 
Bryne et al81 modified this system as they found that deep, invasive cells of the tumor 
appears to be histologically less differentiated than cells in the more superficial parts. They 
included a new parameter “invasive cell grading” into the system proposed by Anneroth et 
al.79 The grading system described by Bryne et al81 consists of five morphological features 
namely degree of keratinization, nuclear polymorphism, number of mitoses, mode of 
invasion and plasma-lymphocytic infiltration. Each of these features was scored from 1 to 4 
according to the definitions given by Anneroth et al79. Only the cells at the deep, invasive 
margins of the tumor were graded. The scores for each morphological feature were summed 
into a total malignancy score. 
9. Prognosis and predictive factors  
Tumor size and nodal status are the most significant prognostic factors. Histological grade 
correlates poorly with patient outcome. The value of grading improves when only the 
deeply invasive margins of the tumor are evaluated. Tumors invading with pushing borders 
are less aggressive than tumors showing a non cohesive front showing diffuse spread with 
tiny strands or single cells. Major risk factors that adversely influence prognosis are two or 
more positive regional nodes, extra capsular extension of nodal disease or positive margins 
of resection. The other important histologic features associated with poor prognosis are 
tumor thickness and vascular invasion83, 84, 85, 86, 87.  
Second Primary Tumors: It has been recognized that patients with oral cancer are at a risk 
of second tumors in the upper aero digestive tract. This has been reported to occur in 10 – 
35% of cases88, 89. These may be synchronous with the index tumor or, if occurring after 
intervals of longer than months are described as metachronous. Recurrence of the index 
tumor after treatment can be diagnosed by the pathologist where the tumor is in deeper 
tissue and not associated with epithelial surface. However, the most frequent situation of the 
second tumors is when they arise from surface epithelium adjacent to the treated index 
tumor. On morphological grounds these are diagnosed as second primary tumors. The 
increasing use of molecular biological techniques has allowed distinction to be made 
between molecularly distinct second primary tumors and second field tumors derived from 
the same genetically altered field as the index tumor.  
10. Glossary 
Oral cancer: Cancer of the lip, tongue, salivary glands, and other sites in the mouth  
Oral Leukoplakia: A predominantly white lesion of the oral mucosa that cannot be 
characterized as any other definable lesion; some oral leukoplakias will transform into cancer.  
Precancerous lesion: A morphologically altered tissue in which cancer is more likely to 
occur than its apparently normal counter part.  
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Quid: Defined as “a substance or mixture of substances placed in the mouth or chewed and 
remaining in contact with the mucosa, in raw or any manufactured or processed form.” 
Clear delineation on contents of the quid (areca quid, tobacco quid and areca and tobacco 
quid) are recommended as absolute criteria for finer sub divisions to be added if necessary. 
Betel quid: The betel quid refers to any quid wrapped in betel leaf and is therefore a specific 
variety of quid 
Nass – a preparation of local tobacco, ash and cotton or sesame oil 
Naswar – a mixture of powdered tobacco, slaked lime, cardamom oil 
Betel quid – fresh betel leaf, fresh areca nut, slaked lime, catechu and tobacco 
Pan masala - areaca nut, slaked lime, catechu, condiments and tobacco 
Mainpuri – Tobacco, slaked lime, arecanut, camphor and cloves 
Mawa – Areca nut, tobacco and slaked lime 
Khainin – Tobacco and slaked lime 
Gutka - An industrially manufactured tobacco and areca product 
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